Sinopharm
1099.HK
#2008
Rank
NZ$13.60 B
Marketcap
$4.36
Share price
-0.74%
Change (1 day)
5.69%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2022: $0.66

According to Sinopharm's latest financial reports the company's current EPS (TTM) is $0.66. In 2022 the company made an earnings per share (EPS) of $0.66 an increase over its 2021 EPS that were of $0.65.

EPS history for Sinopharm from 2006 to 2022

Annual EPS

Year EPS Change
2022$0.661.3%
2021$0.6510.33%
2020$0.5917.26%
2019$0.515.44%
2018$0.48-0.87%
2017$0.4819.44%
2016$0.4115.3%
2015$0.3517.06%
2014$0.3021.9%
2013$0.2511.82%
2012$0.2225.24%
2011$0.1831.02%
2010$0.133.3%
2009$0.1346.85%
2008$0.0884867.57%
2007$0.05280310.24%
2006$0.01287